Cardiovascular Systems Reports Fiscal 2016 Third-Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Leerink Partners Raises Price Target as Cardiovascular Systems (CSII) Reports Above Preannouncement
May 5, 2016 8:52 AM EDTLeerink Partners reiterated a Market Perform rating on Cardiovascular Systems (NASDAQ: CSII), and raised the price target to $15.00 (from $13.00), following the company's 3Q earnings report. CSII reported sales of $44.5M, slightly above its preannounced range of $43.5M-$44M. Leerink continues to view CSII's longterm... More
Cardiovascular Systems (CSII) Offers Three-Year Data from Pivotal ORBIT II Study
May 5, 2016 8:08 AM EDTCardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) shared three-year results from its pivotal ORBIT II study in a featured clinical research presentation at the 2016 Society for Cardiovascular Angiography and Interventions (SCAI) conference in Orlando, Florida.
The ORBIT II study evaluated the safety and efficacy of the companys Diamondback 360® Coronary Orbital Atherectomy System... More
Cardiovascular Systems (CSII) Misses Q3 EPS by 15c
May 4, 2016 5:36 PM EDTCardiovascular Systems (NASDAQ: CSII) reported Q3 EPS of ($0.69), $0.15 worse than the analyst estimate of ($0.54). Revenue for the quarter came in at $44.5 million versus the consensus estimate of $42.13 million.
Scott Ward, CSIs Chairman, Interim President and Chief Executive Officer, said, This quarter we made... More
